Physician profile
Patrick Wald
NPI 1851634943
$381.94
in general payments reported to CMS, 2019-2025
11 companies · $57.98 in 2025
The $57.98 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $46.82 · 2022: $157 · 2023: $80.73 · 2024: $39.32 · 2025: $57.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $178.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $178.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $100.96 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $86.95 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $38.26 | 2022-2023 | |
| Blue Earth Diagnostics | $25.81 | 2020 | |
| Boston Scientific Corporation | $23.74 | 2022 | |
| Bioprotect Medical, INC. | $22.33 | 2024 | Bioprotect Balloon Implant System |
| Beigene USA, INC. | $21.01 | 2020 | |
| Teleflex LLC | $20.66 | 2025 | Barrigel |
| Janssen Biotech, INC. | $15.45 | 2025 | Tecvayli, Talvey |
| Advanced Critical Devices, INC. | $14.80 | 2023 | |
| Cumberland Pharmaceuticals, INC. | $11.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Wald listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.